Last viewed: NEPH


Prices are updated after-hours



nasdaq:NEPH Nephros, Inc.

NEPH | $5.25 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-18.0% 1m) (-34.3% 1y) (-2.8% 2d) (-6.2% 3d) (0.0% 7d) (-39.01% volume)
http://www.nephros.com
Sec Filling | Patents | 25 employees

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Renal Products segment comprises of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.

add to today's watch list email alert is off




renal   treatment  

Press-releases


RION Appoints Alisa Lask as Chief Commercial Officer
Published: 2022-01-14 (Crawled : 14:30) - biospace.com/
LLY | $245.05 | twitter stocktwits trandingview |
Health Technology
| | O: -1.46% H: 0.0% C: 0.0%
NEPH | $5.25 | twitter stocktwits trandingview |
Health Technology
| | O: 0.19% H: 0.0% C: -2.96%
CLGN | $11.69 | twitter stocktwits trandingview |
Health Technology
| | O: 4.18% H: 0.0% C: 0.0%


Nephros Issues 2022 Shareholder Letter
Published: 2022-01-13 (Crawled : 13:30) - biospace.com/
NEPH | $5.25 | twitter stocktwits trandingview |
Health Technology
| | O: 0.89% H: 1.44% C: -4.42%


Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2021 and Revenue Guidance for 2022
Published: 2022-01-11 (Crawled : 13:00) - biospace.com/
NEPH | $5.25 | twitter stocktwits trandingview |
Health Technology
| | O: 2.12% H: 1.9% C: -0.35%


Nephros to Present at the Benchmark Company 10th Annual One-on-One Discovery Conference
Published: 2021-11-23 (Crawled : 22:00) - globenewswire.com
NEPH | $5.25 | twitter stocktwits trandingview |
Health Technology
| | O: -1.1% H: 2.51% C: 2.51%

conference
Nephros Announces Third Quarter 2021 Financial Results Conference Call
Published: 2021-10-21 (Crawled : 12:00) - globenewswire.com
FNCTF | News | $11.19 | twitter stocktwits trandingview |
Communications
| | O: 1.76% H: 0.0% C: -0.35%
NEPH | $5.25 | twitter stocktwits trandingview |
Health Technology
| | O: -0.8% H: 1.01% C: 0.67%

financial results results conference
Nephros Announces Preliminary Results for Third Quarter of 2021
Published: 2021-10-08 (Crawled : 12:15) - biospace.com/
NEPH | $5.25 | twitter stocktwits trandingview |
Health Technology
| | O: -0.38% H: 4.97% C: 2.04%

results
Nephros to Present at the LD Micro Main Event
Published: 2021-10-05 (Crawled : 12:15) - biospace.com/
FNCTF | News | $11.19 | twitter stocktwits trandingview |
Communications
| | O: -4.27% H: 0.0% C: 0.0%
NEPH | $5.25 | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.59% C: 0.0%

presentation
Nephros to Present at the Virtual MicroCap Leadership Summit
Published: 2021-09-15 (Crawled : 14:00) - globenewswire.com
NEPH | $5.25 | twitter stocktwits trandingview |
Health Technology
| | O: -2.65% H: 11.31% C: 11.31%

presentation
Nephros Appoints Wes Lobo to Chief Commercial Officer
Published: 2021-09-01 (Crawled : 12:00) - globenewswire.com
NEPH | $5.25 | twitter stocktwits trandingview |
Health Technology
| | O: 2.19% H: 0.97% C: 0.97%


Nephros Announces Acquisition of GenArraytion, Inc.
Published: 2021-07-12 (Crawled : 12:00) - globenewswire.com
NEPH | $5.25 | twitter stocktwits trandingview |
Health Technology
| | O: 3.97% H: 2.15% C: 0.32%

acquisition
See all


Last 15 days Sec forms
File Id Form Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Today's Insiders Buying

Yesterday's Insiders Buying